Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Somnus Medical floats to raise $42 million:

This article was originally published in Clinica

Executive Summary

Somnus Medical Technologies, which manufactures products for the treatment of upper airway disorders, has raised $42 million in an initial public offering in the US. The company sold four million shares at $10.50 each. Somnus' products use its radiofrequency technology. In July the company received FDA approval for its Somnoplasty system for the treatment of habitual snoring (see Clinica No 768, p 13). The product uses radiofrequency energy to ablate part of the soft palate and uvula.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT086625

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel